Given sleep’s profound impact on well-being, unexplained daytime fatigue and disrupted sleep patterns necessitate a ...

A new survey from the National Sleep Foundation reveals nearly 90% of Americans say sleep apnea is a serious condition.

Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced its home sleep apnea test, NightOwl™, is now available ...

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea.  | ...

These findings imply that brain stimulation could deliver some of the benefits of naps without sleep. The results in primates ...

For people with a certain sleep disorder, a simple blood test could help predict the development of dementia years before ...

According to a multicenter validation study, NightOwl results using peripheral arterial tonometry technology showed close agreement with expert scored sleep lab testing PSG in its estimate of ...

NightOwl is an FDA-cleared home sleep apnea test (HSAT) designed to offer healthcare providers a simplified, accurate, and efficient way to diagnose obstructive sleep apnea (OSA) from the comfort ...

A new study from McGill University has found that a simple blood test could help predict the risk of developing dementia ...